We administered TAC(oxaliplatin,FUDR and MMC) 7 days before liver metastasis resection of colorectal cancer. The study endpoints were progression free survival and overall survival as evaluated by intent-to-treat analysis.
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
age \<= 75 years
resectable liver metastasis
remnant liver volume \>= 70%
without other organ metastasis or peritoneum metastasis
without contradiction of cardiac and pulmonary diseases
You may not be if
age \> 75 years
unresectable liver metastasis
remnant liver volume \< 50%
with other organ metastasis or peritoneum metastasis
with contradiction of cardiac and pulmonary diseases
Clareo Health | Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer
